Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Growth (Status and Outlook) 2021-2026

Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Growth (Status and Outlook) 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2016-2026
2.1.2 Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Segment by Type
2.2.1 Single-stranded AAV (ssAAV)
2.2.2 Single-stranded AAV (ssAAV)
2.3 Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Type
2.3.1 Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size CAGR by Type
2.3.2 Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Type (2016-2021)
2.4 Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Segment by Application
2.4.1 Hemophilia
2.4.2 Ophthalmology
2.4.3 Lysosomal Storage Disorders
2.4.4 Neurological Disorders
2.4.5 Others
2.5 Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Application
2.5.1 Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size CAGR by Application
2.5.2 Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Application (2016-2021)

3 Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Players
3.1 Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Players
3.1.1 Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue by Players (2019-2021E)
3.1.2 Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue Market Share by Players (2019-2021E)
3.2 Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Adeno-Associated Virus (AAV) Vector-Based Gene Therapy by Regions
4.1 Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Regions (2016-2021)
4.2 Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth (2016-2021)
4.3 APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth (2016-2021)
4.4 Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth (2016-2021)
4.5 Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth (2016-2021)

5 Americas
5.1 Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Country (2016-2021)
5.2 Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Type (2016-2021)
5.3 Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Region (2016-2021)
6.2 APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Type (2016-2021)
6.3 APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy by Country (2016-2021)
7.2 Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Type (2016-2021)
7.3 Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy by Region (2016-2021)
8.2 Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Type (2016-2021)
8.3 Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.1 Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Forecast by Regions (2021-2026)
10.1.1 Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Forecast by Regions (2021-2026)
10.1.2 Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Forecast
10.1.3 APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Forecast
10.1.4 Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Forecast
10.1.5 Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Forecast
10.2 Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Forecast by Countries (2021-2026)
10.2.1 United States Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.2.2 Canada Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.2.3 Mexico Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.2.4 Brazil Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.3 APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Forecast by Region (2021-2026)
10.3.1 China Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.3.2 Japan Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.3.3 Korea Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.3.4 Southeast Asia Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.3.5 India Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.3.6 Australia Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.4 Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Forecast by Country (2021-2026)
10.4.1 Germany Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.4.2 France Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.4.3 UK Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.4.4 Italy Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.4.5 Russia Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.5 Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Forecast by Region (2021-2026)
10.5.1 Egypt Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.5.2 South Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.5.3 Israel Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.5.4 Turkey Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.5.5 GCC Countries Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Forecast
10.6 Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Forecast by Type (2021-2026)
10.7 Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 BioMarin Pharmaceutical
11.1.1 BioMarin Pharmaceutical Company Information
11.1.2 BioMarin Pharmaceutical Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
11.1.3 BioMarin Pharmaceutical Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 BioMarin Pharmaceutical Main Business Overview
11.1.5 BioMarin Pharmaceutical Latest Developments
11.2 Sangamo Therapeutics
11.2.1 Sangamo Therapeutics Company Information
11.2.2 Sangamo Therapeutics Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
11.2.3 Sangamo Therapeutics Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Sangamo Therapeutics Main Business Overview
11.2.5 Sangamo Therapeutics Latest Developments
11.3 Amicus Therapeutics
11.3.1 Amicus Therapeutics Company Information
11.3.2 Amicus Therapeutics Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
11.3.3 Amicus Therapeutics Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Amicus Therapeutics Main Business Overview
11.3.5 Amicus Therapeutics Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
11.4.3 Roche Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
11.5.3 Pfizer Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 NightstaRx
11.6.1 NightstaRx Company Information
11.6.2 NightstaRx Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
11.6.3 NightstaRx Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 NightstaRx Main Business Overview
11.6.5 NightstaRx Latest Developments
11.7 MeiraGTx
11.7.1 MeiraGTx Company Information
11.7.2 MeiraGTx Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
11.7.3 MeiraGTx Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 MeiraGTx Main Business Overview
11.7.5 MeiraGTx Latest Developments
11.8 Sarepta Therapeutics
11.8.1 Sarepta Therapeutics Company Information
11.8.2 Sarepta Therapeutics Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
11.8.3 Sarepta Therapeutics Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Sarepta Therapeutics Main Business Overview
11.8.5 Sarepta Therapeutics Latest Developments
11.9 Neurocrine Biosciences
11.9.1 Neurocrine Biosciences Company Information
11.9.2 Neurocrine Biosciences Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
11.9.3 Neurocrine Biosciences Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Neurocrine Biosciences Main Business Overview
11.9.5 Neurocrine Biosciences Latest Developments
11.10 Voyager Therapeutics
11.10.1 Voyager Therapeutics Company Information
11.10.2 Voyager Therapeutics Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
11.10.3 Voyager Therapeutics Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Voyager Therapeutics Main Business Overview
11.10.5 Voyager Therapeutics Latest Developments
11. Asklepios Biopharmaceutical
11.11.1 Asklepios Biopharmaceutical Company Information
11.11.2 Asklepios Biopharmaceutical Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
11.11.3 Asklepios Biopharmaceutical Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Asklepios Biopharmaceutical Main Business Overview
11.11.5 Asklepios Biopharmaceutical Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Single-stranded AAV (ssAAV)
Table 3. Major Players of Self-complementary AAV (scAAV)
Table 4. Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Type (2016-2021)
Table 7. Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Application (2016-2021)
Table 10. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue Market Share by Players (2019-2021E)
Table 12. Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Key Players Head office and Products Offered
Table 13. Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Regions 2016-2021
Table 18. Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Country (2016-2021)
Table 20. Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Type (2016-2021)
Table 22. Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Application (2016-2021)
Table 24. APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Region (2016-2021)
Table 26. APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Type (2016-2021)
Table 28. APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Application (2016-2021)
Table 30. Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Country (2016-2021)
Table 32. Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Type (2016-2021)
Table 34. Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Adeno-Associated Virus (AAV) Vector-Based Gene Therapy
Table 43. Key Application and Potential Industries of Adeno-Associated Virus (AAV) Vector-Based Gene Therapy
Table 44. Key Challenges of Adeno-Associated Virus (AAV) Vector-Based Gene Therapy
Table 45. Key Trends of Adeno-Associated Virus (AAV) Vector-Based Gene Therapy
Table 46. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share Forecast by Application (2021-2026)
Table 52. BioMarin Pharmaceutical Details, Company Type, Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Area Served and Its Competitors
Table 53. BioMarin Pharmaceutical Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
Table 54. BioMarin Pharmaceutical Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. BioMarin Pharmaceutical Main Business
Table 56. BioMarin Pharmaceutical Latest Developments
Table 57. Sangamo Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Area Served and Its Competitors
Table 58. Sangamo Therapeutics Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
Table 59. Sangamo Therapeutics Main Business
Table 60. Sangamo Therapeutics Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Sangamo Therapeutics Latest Developments
Table 62. Amicus Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Area Served and Its Competitors
Table 63. Amicus Therapeutics Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
Table 64. Amicus Therapeutics Main Business
Table 65. Amicus Therapeutics Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Amicus Therapeutics Latest Developments
Table 67. Roche Details, Company Type, Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Area Served and Its Competitors
Table 68. Roche Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
Table 69. Roche Main Business
Table 70. Roche Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Roche Latest Developments
Table 72. Pfizer Details, Company Type, Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Area Served and Its Competitors
Table 73. Pfizer Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
Table 74. Pfizer Main Business
Table 75. Pfizer Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. Pfizer Latest Developments
Table 77. NightstaRx Details, Company Type, Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Area Served and Its Competitors
Table 78. NightstaRx Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
Table 79. NightstaRx Main Business
Table 80. NightstaRx Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. NightstaRx Latest Developments
Table 82. MeiraGTx Details, Company Type, Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Area Served and Its Competitors
Table 83. MeiraGTx Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
Table 84. MeiraGTx Main Business
Table 85. MeiraGTx Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. MeiraGTx Latest Developments
Table 87. Sarepta Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Area Served and Its Competitors
Table 88. Sarepta Therapeutics Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
Table 89. Sarepta Therapeutics Main Business
Table 90. Sarepta Therapeutics Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. Sarepta Therapeutics Latest Developments
Table 92. Neurocrine Biosciences Details, Company Type, Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Area Served and Its Competitors
Table 93. Neurocrine Biosciences Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
Table 94. Neurocrine Biosciences Main Business
Table 95. Neurocrine Biosciences Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. Neurocrine Biosciences Latest Developments
Table 97. Voyager Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Area Served and Its Competitors
Table 98. Voyager Therapeutics Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
Table 99. Voyager Therapeutics Main Business
Table 100. Voyager Therapeutics Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. Voyager Therapeutics Latest Developments
Table 102. Asklepios Biopharmaceutical Details, Company Type, Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Area Served and Its Competitors
Table 103. Asklepios Biopharmaceutical Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Product Offered
Table 104. Asklepios Biopharmaceutical Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 105. Asklepios Biopharmaceutical Main Business
Table 106. Asklepios Biopharmaceutical Latest Developments
List of Figures
Figure 1. Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Type in 2020
Figure 7. Adeno-Associated Virus (AAV) Vector-Based Gene Therapy in Hemophilia
Figure 8. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market: Hemophilia (2016-2021) & ($ Millions)
Figure 9. Adeno-Associated Virus (AAV) Vector-Based Gene Therapy in Ophthalmology
Figure 10. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market: Ophthalmology (2016-2021) & ($ Millions)
Figure 11. Adeno-Associated Virus (AAV) Vector-Based Gene Therapy in Lysosomal Storage Disorders
Figure 12. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market: Lysosomal Storage Disorders (2016-2021) & ($ Millions)
Figure 13. Adeno-Associated Virus (AAV) Vector-Based Gene Therapy in Neurological Disorders
Figure 14. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market: Neurological Disorders (2016-2021) & ($ Millions)
Figure 15. Adeno-Associated Virus (AAV) Vector-Based Gene Therapy in Others
Figure 16. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market: Others (2016-2021) & ($ Millions)
Figure 17. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Application in 2020
Figure 18. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Revenue Market Share by Player in 2020
Figure 19. Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Regions (2016-2021)
Figure 20. Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2016-2021 ($ Millions)
Figure 21. APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2016-2021 ($ Millions)
Figure 22. Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2016-2021 ($ Millions)
Figure 23. Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2016-2021 ($ Millions)
Figure 24. Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Country in 2020
Figure 25. Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Type in 2020
Figure 26. Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Application in 2020
Figure 27. United States Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 28. Canada Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 29. Mexico Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 30. APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Regions in 2020
Figure 31. APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Type in 2020
Figure 32. APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Application in 2020
Figure 33. China Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 34. Japan Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 35. Korea Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 36. Southeast Asia Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 37. India Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 38. Australia Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 39. Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Country in 2020
Figure 40. Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Type in 2020
Figure 41. Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Application in 2020
Figure 42. Germany Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 43. France Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 44. UK Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 45. Italy Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 46. Russia Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 47. Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Region in 2020
Figure 48. Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Type in 2020
Figure 49. Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Market Share by Application in 2020
Figure 50. Egypt Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 51. South Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 52. Israel Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 53. Turkey Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 54. GCC Country Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 55. Americas Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 56. APAC Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 57. Europe Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 58. Middle East & Africa Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 59. United States Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 60. Canada Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 61. Mexico Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 62. Brazil Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 63. China Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 64. Japan Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 65. Korea Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 66. Southeast Asia Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 67. India Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 68. Australia Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 69. Germany Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 70. France Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 71. UK Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 72. Italy Adeno-Associ

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs